Skip to main content
search

Vaccine Simulator

Optimize vaccine strategies for better patient outcomes

QSP model to guide and inform vaccine dosing

Certara’s Vaccine Simulator is a cutting-edge tool that employs Quantitative Systems Pharmacology (QSP) modeling to determine optimal vaccine dosing strategies. By integrating data from extensive clinical studies, the Vaccine Simulator develops sophisticated models to answer critical “what-if” scenarios. Using 32 clinical datasets, 3 vaccines, 8 dosing regimens, and 10 biomarkers, a novel model was developed. This model is instrumental in identifying the best dosing strategies for various patient groups, including vulnerable populations like the elderly and children. Trusted by global pharmaceutical companies, the Vaccine Simulator has been presented to regulatory agencies, including the FDA, showcasing its reliability and impact.

Certara’s Vaccine Simulator is built on a robust foundation of QSP technology, calibrated with data from over 20 clinical cases. This innovative platform allows pharmaceutical companies to simulate trial outcomes, predict vaccine efficacy, and optimize dosing regimens.

Provides insights into patient-specific dosing strategies
Links biomarkers to clinical endpoints for comprehensive analysis
Validated through collaboration with seven major pharmaceutical companies

Speak to a QSP expert

Learn about how Certara’s Vaccine Simulator can transform your vaccine development process.

Optimize vaccine dosing strategies with QSP
Simulate clinical outcomes for diverse patient populations
Trusted by leading pharmaceutical companies and regulatory agencies